AMA statement on FDA approval of implant to fight opioid addiction

| 1 Min Read

"The AMA is pleased the FDA approved a new implantable option to help treat patients with substance use disorders. With nearly 2 million Americans needing treatment for opioid use disorder, patients will benefit from increased options for medication-assisted treatment.

 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Three healthcare workers in discussion

Author of landmark study on NPs in ED: This needs to come next

| 11 Min Read
Hand holds a checklist

Measuring physician burnout? Ask better questions

| 9 Min Read
Figures construct an up arrow

Peer support boosts well-being and value. Start your program here.

| 7 Min Read
Person salting a bowl of french fries

What doctors want patients to know about sodium consumption

| 13 Min Read